Researchers from the National Defense Medical Center in Taiwan have identified an increased risk of psoriasis in patients ...

The immune system is a major target for cancer treatments. Immune checkpoint inhibitors and CAR-T cell therapy can ...

The combination of THIO and Libtayo has shown promising results among patients with advanced checkpoint inhibitor-resistant ...

Source: Getty Images Clinicians should have a standard approach for discussing the risk of adverse events associated with immune checkpoint inhibitors, researchers say. The most common immune-related ...

Some patients being treated with immune checkpoint inhibitors, a type of cancer immunotherapy, develop a dangerous form of heart inflammation called myocarditis.

Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but many patients with metastatic cancer develop resistance. Understanding the mechanisms behind this resistance is ...

Researchers think they've figured out why cancer treatments that harness a person's immune system to fight a tumor can cause ...

By Ayako Wakatsuki Pedersen, Ph.D., Senior Vice President of Translational Research at IO Biotech | Making the tumor microenvironment hostile to cancer cells and immune-suppressive cells may transform ...

Researchers at the University of Michigan Rogel Cancer Center have discovered a key reason why some cancers do not respond to ...

Patients with metastatic RCC who are assigned to the control arms of ICI trials are not consistently given ICIs after their ...

Beyond Cancer announced key data demonstrating the efficacy of Low Volume Ultra-High Concentration Nitric Oxide, LV UNO, when combined with ...

Median overall survival (OS) increased from 19.3 months with upfront immune checkpoint inhibition (ICI) to 41.3 months when a ...